← Leaderboards
Thomas P Richardson
Plumeria Therapeutics, Inc.
$2,130,065
Attributed
$2,480,129
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,480,129 · 3
By mechanism
R44$1,500,000 · 1
R43$980,129 · 2
Top collaborators
- Yiping Wang1 shared
Others in their field
Other Emerging Leaders on “Area”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Leonard Freedman · Leidos Biomedical Research, Inc.$164,467,481
Research focus
AreaQuality Of LifeNeuropathySmall Business Innovation Research GrantEconomic CostReceptorGeneticNeuroinflammationProgramsSamplingDrug IndustryChemokineChemokine ReceptorChronic PainAffectClinical TrialsInvestmentsClinical DevelopmentPainPharmaceutical PreparationsGenetic ProfilingHealthcareDiabetes MellitusComplex
Grant awards (4)
Laboratory Developed Test (LDT) to Support Clinical Evaluation of a Drug for Painful Diabetic Neuropathy$1,500,000
R44 · FY2025 · NS · contact PI
Chemokine-receptor profiling for painful diabetic neuropathy in biological samples from human clinical trials$700,128
R43 · FY2021 · NS · contact PI
Chemokine-receptor expression profiling in biological samples from human clinical trials$55,000
R43 · FY2019 · NS · contact PI
Chemokine-receptor expression profiling in biological samples from human clinical trials$225,001
R43 · FY2018 · NS · contact PI